As one of the first PGT laboratories in the world, RGI offers state-of-the-art technologies, a comprehensive range of Preimplantation Genetic Testing (PGT).
PGT is performed in conjunction with an In Vitro Fertilization (IVF) cycle and can significantly reduce the chances of having a baby with a specific genetic condition or chromosomal abnormality. There are various types of PGT available, depending on the needs of the individual couple. We offer the four PGT options below. The testing options can can be combined.
PGT-A
for Aneuploidy
PGT-M
for Monogenic for Single Gene Disorders
PGT-SR
for Structural Rearrangements
PGT-HLA
for Human Leukocyte Antigen
PGT-A
PGT-A helps reduce the chance of failed implantation or an early miscarriage, or of having a child with a chromosome abnormality (which can cause birth defects and intellectual disabilities), and increases the chances of a healthy pregnancy after an IVF cycle.
PGT-M
PGT-M allows for selection of embryos, free of genetic disorder while avoiding the difficult decision about the outcome of a pregnancy following abnormal prenatal test results. RGI tests for rare conditions, offering specific test set-ups not available at other labs.
PGT-SR
PGT-SR allows for a viable pregnancy, reducing or avoiding the chance of a failed implantation, miscarriage and/or the birth of a child with congenital anomalies, resulting from an unbalanced chromosome translocation.
PGT-HLA
PGT-HLA for HLA Matching is requested by couples where a previous child is in need of a bone marrow or cord blood transplant due to a genetic disorder. In planning future pregnancy, not only is it desired to have a child without the disorder, but an HLA-compatible child whose umbilical cord blood can be used for stem cell transplantation, to provide normally functioning bone marrow.